Literature DB >> 31331922

DAPSA versus cDAPSA: Do we need to use CRP?

Rafaela Silva Guimarães Gonçalves1, Lays Miranda de Almeida Martins2, Henrique de Ataide Mariz2, Andrea Tavares Dantas2, Angela Luzia Branco Pinto Duarte2.   

Abstract

Keywords:  disease activity; psoriatic arthritis; spondyloarthritis

Mesh：

Substances：

Year:  2019        PMID： 31331922     DOI： 10.1136/annrheumdis-2019-215960

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice.

Authors:  Chrysoula G Gialouri; Gerasimos Evangelatos; Maria Pappa; Anastasios Karamanakos; Alexios Iliopoulos; Maria G Tektonidou; Petros P Sfikakis; George E Fragoulis
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-05       Impact factor: 3.625

2.  PET/CT-Based Characterization of 18F-FDG Uptake in Various Tissues Reveals Novel Potential Contributions to Coronary Artery Disease in Psoriatic Arthritis.

Authors:  Daniella M Schwartz; Philip Parel; Haiou Li; Alexander V Sorokin; Alexander R Berg; Marcus Chen; Amit Dey; Christin G Hong; Martin Playford; McKella Sylvester; Heather Teague; Evan Siegel; Nehal N Mehta
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

3.  Differences in oxylipin profile in psoriasis versus psoriatic arthritis.

Authors:  Roxana Coras; Arthur Kavanaugh; Angela Kluzniak; Dustina Holt; Amy Weilgosz; Armando Aaron; Oswald Quehenberger; Christopher Ritchlin; Monica Guma
Journal:  Arthritis Res Ther       Date:  2021-07-24       Impact factor: 5.156
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.